Clinical Trial Update: Bone Marrow Aspirate Concentrate (BMAC) for Treatment of Critical Limb Ischemia (CLI) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Bone Marrow Aspirate Concentrate (BMAC) for critical limb ischemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Bone Marrow Aspirate Concentrate (BMAC) (bone marrow aspirate concentrate)

Snippet

Sponsor: Harvest Technologies | Conditions: Critical Limb Ischemia | Phase 3 | Status: COMPLETED